Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1984 Dec;50(6):793–800. doi: 10.1038/bjc.1984.258

Synergistic growth inhibiting effect of nitrous oxide and cycloleucine in experimental rat leukaemia.

A C Kroes, J Lindemans, J Abels
PMCID: PMC1977016  PMID: 6498076

Abstract

Nitrous oxide (N2O) inactivates the vitamin B12-dependent enzyme methionine synthetase with subsequent impairment of folate metabolism and a reduction of cellular proliferation. Indications exist that this effect is antagonized by S-adenosylmethionine (SAM), and it was investigated whether combination with an inhibitor of SAM synthesis, cycloleucine, would result in increased inhibition of growth in rat leukaemia model (BNML). Leukaemic growth was compared in untreated rats, in rats treated with either nitrous oxide/oxygen (1:1) or cycloleucine (50 mg kg-1 i.p.), and in rats receiving both agents. Combined treatment resulted in the strongest reduction of leukaemic infiltration in spleen and liver, and this reduction often was more than the added effects of single treatments. Peripheral leukocyte counts were also lowest after combined treatment. The deoxyuridine suppression test, measuring folate-dependent de novo synthesis of thymidine, was more severely disturbed with combined treatment. Levels of vitamin B12 in plasma were reduced in rats receiving N2O, but an increase in plasma folate occurred in all treated rats. These results indicate that a reduction of SAM synthesis by cycloleucine can increase the disturbance of folate metabolism that is caused by nitrous oxide, with a potentiation of the effects on leukaemic growth.

Full text

PDF
793

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Amess J. A., Burman J. F., Rees G. M., Nancekievill D. G., Mollin D. L. Megaloblastic haemopoiesis in patients receiving nitrous oxide. Lancet. 1978 Aug 12;2(8085):339–342. doi: 10.1016/s0140-6736(78)92941-0. [DOI] [PubMed] [Google Scholar]
  2. Billings R. E., Noker P. E., Tephly T. R. The role of methionine in regulating folate-dependent reactions in isolated rat hepatocytes. Arch Biochem Biophys. 1981 Apr 15;208(1):108–120. doi: 10.1016/0003-9861(81)90129-6. [DOI] [PubMed] [Google Scholar]
  3. CHRISTENSEN H. N., CLIFFORD J. A. Excretion of 1-aminocyclopentanecarboxylic acid in man and the rat. Biochim Biophys Acta. 1962 Jul 30;62:160–162. doi: 10.1016/0006-3002(62)90501-2. [DOI] [PubMed] [Google Scholar]
  4. CONNORS T. A., ELSON L. A., HADDOW A., ROSS W. C. The pharmacology and tumour growth inhibitory activity of 1-aminocyclopentane-1-carboxylic acid and related compounds. Biochem Pharmacol. 1960 Oct;5:108–129. doi: 10.1016/0006-2952(60)90014-9. [DOI] [PubMed] [Google Scholar]
  5. Caboche M., Hatzfeld J. Methionine metabolism in BHK cells: preliminary characterization of the physiological effects of cycloleucine, an inhibitor of s-adenosylmethionine biosynthesis. J Cell Physiol. 1978 Dec;97(3 Pt 1):361–370. doi: 10.1002/jcp.1040970311. [DOI] [PubMed] [Google Scholar]
  6. Deacon R., Lumb M., Perry J., Chanarin I., Minty B., Halsey M., Nunn J. Inactivation of methionine synthase by nitrous oxide. Eur J Biochem. 1980 Mar;104(2):419–423. doi: 10.1111/j.1432-1033.1980.tb04443.x. [DOI] [PubMed] [Google Scholar]
  7. Dindogru A., Leichman L. P., Cummings G., Baker L. H. Phase II study of high-dose intermittent cycloleucine in colorectal malignancies. Cancer Treat Rep. 1982 Jan;66(1):203–204. [PubMed] [Google Scholar]
  8. Eells J. T., Black K. A., Makar A. B., Tedford C. E., Tephly T. R. The regulation of one-carbon oxidation in the rat by nitrous oxide and methionine. Arch Biochem Biophys. 1982 Dec;219(2):316–326. doi: 10.1016/0003-9861(82)90162-x. [DOI] [PubMed] [Google Scholar]
  9. GREEN C. D., EASTWOOD D. W. Effects of nitrous oxide inhalation on hemopoiesis in rats. Anesthesiology. 1963 May-Jun;24:341–345. doi: 10.1097/00000542-196305000-00015. [DOI] [PubMed] [Google Scholar]
  10. Gutcho S., Mansbach L. Simultaneous radioassay of serum vitamin B12 and folic acid. Clin Chem. 1977 Sep;23(9):1609–1614. [PubMed] [Google Scholar]
  11. Johnson M. C., Swartz H. M., Donati R. M. Hematologic alterations produced by nitrous oxide. Anesthesiology. 1971 Jan;34(1):42–49. doi: 10.1097/00000542-197101000-00014. [DOI] [PubMed] [Google Scholar]
  12. Kano Y., Sakamoto S., Sakuraya K., Kubota T., Kasahara T., Hida K., Suda K., Takaku F. Effects of nitrous oxide on human cell lines. Cancer Res. 1983 Apr;43(4):1493–1496. [PubMed] [Google Scholar]
  13. Kelly D. A., Scott J. M., Weir D. G. Increased folate catabolism in mice with ascitic tumours. Clin Sci (Lond) 1983 Sep;65(3):303–305. doi: 10.1042/cs0650303. [DOI] [PubMed] [Google Scholar]
  14. Kondo H., Osborne M. L., Kolhouse J. F., Binder M. J., Podell E. R., Utley C. S., Abrams R. S., Allen R. H. Nitrous oxide has multiple deleterious effects on cobalamin metabolism and causes decreases in activities of both mammalian cobalamin-dependent enzymes in rats. J Clin Invest. 1981 May;67(5):1270–1283. doi: 10.1172/JCI110155. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Kroes A. C., Lindemans J., Hagenbeek A., Abels J. Nitrous oxide reduces growth of experimental rat leukemia. Leuk Res. 1984;8(3):441–448. doi: 10.1016/0145-2126(84)90085-7. [DOI] [PubMed] [Google Scholar]
  16. Kutzbach C., Stokstad E. L. Feedback inhibition of methylene-tetrahydrofolate reductase in rat liver by S-adenosylmethionine. Biochim Biophys Acta. 1967 May 16;139(1):217–220. doi: 10.1016/0005-2744(67)90140-4. [DOI] [PubMed] [Google Scholar]
  17. LASSEN H. C., HENRIKSEN E., NEUKIRCH F., KRISTENSEN H. S. Treatment of tetanus; severe bone-marrow depression after prolonged nitrous-oxide anaesthesia. Lancet. 1956 Apr 28;270(6922):527–530. doi: 10.1016/s0140-6736(56)90593-1. [DOI] [PubMed] [Google Scholar]
  18. LASSEN H. C., KRISTENSEN H. S. Remission in chronic myeloid leucaemia following prolonged nitrous oxide inhalation. Dan Med Bull. 1959 Nov;6:252–255. [PubMed] [Google Scholar]
  19. Lombardini J. B., Coulter A. W., Talalay P. Analogues of methionine as substrates and inhibitors of the methionine adenosyltransferase reaction. Deductions concerning the conformation of methionine. Mol Pharmacol. 1970 Sep;6(5):481–499. [PubMed] [Google Scholar]
  20. Lumb M., Perry J., Deacon R., Chanarin I. Changes in plasma folate levels in rats inhaling nitrous oxide. Scand J Haematol. 1981 Jan;26(1):61–64. doi: 10.1111/j.1600-0609.1981.tb01625.x. [DOI] [PubMed] [Google Scholar]
  21. Lumb M., Sharer N., Deacon R., Jennings P., Purkiss P., Perry J., Chanarin I. Effects of nitrous oxide-induced inactivation of cobalamin on methionine and S-adenosylmethionine metabolism in the rat. Biochim Biophys Acta. 1983 Apr 20;756(3):354–359. doi: 10.1016/0304-4165(83)90345-8. [DOI] [PubMed] [Google Scholar]
  22. Makar A. B., Tephly T. R. Effect of nitrous oxide and methionine treatments on hepatic S-adenosylmethionine and methylation reactions in the rat. Mol Pharmacol. 1983 Jul;24(1):124–128. [PubMed] [Google Scholar]
  23. McKenna B., Weir D. G., Scott J. M. The induction of functional vitamin B-12 deficiency in rats by exposure to nitrous oxide. Biochim Biophys Acta. 1980 Mar 20;628(3):314–321. doi: 10.1016/0304-4165(80)90380-3. [DOI] [PubMed] [Google Scholar]
  24. Metz J., Kelly A., Swett V. C., Waxman S., Herbert V. Deranged DNA synthesis by bone marrow from vitamin B-12-deficient humans. Br J Haematol. 1968 Jun;14(6):575–592. doi: 10.1111/j.1365-2141.1968.tb00364.x. [DOI] [PubMed] [Google Scholar]
  25. Parbrook G. D. Leucopenic effects of prolonged nitrous oxide treatment. Br J Anaesth. 1967 Feb;39(2):119–127. doi: 10.1093/bja/39.2.119. [DOI] [PubMed] [Google Scholar]
  26. Perry J., Chanarin I., Deacon R., Lumb M. Chronic cobalamin inactivation impairs folate polyglutamate synthesis in the rat. J Clin Invest. 1983 May;71(5):1183–1190. doi: 10.1172/JCI110867. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. ROSS R. B., NOLL C. I., ROSS W. C., NADKARNI M. V., MORRISON B. H., Jr, BOND H. W. Cycloaliphatic amino acids in cancer chemotherapy. J Med Pharm Chem. 1961 Jan 10;3:1–23. doi: 10.1021/jm50014a001. [DOI] [PubMed] [Google Scholar]
  28. Savlov E. D., MacIntyre J. M., Knight E., Wolter J. Comparison of doxorubicin with cycloleucine in the treatment of sarcomas. Cancer Treat Rep. 1981 Jan-Feb;65(1-2):21–27. [PubMed] [Google Scholar]
  29. Scott J. M., Dinn J. J., Wilson P., Weir D. G. Pathogenesis of subacute combined degeneration: a result of methyl group deficiency. Lancet. 1981 Aug 15;2(8242):334–337. doi: 10.1016/s0140-6736(81)90649-8. [DOI] [PubMed] [Google Scholar]
  30. van der Westhuyzen J., Fernandes-Costa F., Metz J. Cobalamin inactivation by nitrous oxide produces severe neurological impairment in fruit bats : protection by methionine and aggravation by folates. Life Sci. 1982 Nov 1;31(18):2001–2010. doi: 10.1016/0024-3205(82)90039-x. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES